How we diagnose and treat hereditary transthyretin-mediated amyloidosis with polyneuropathy in the Balkan region: an expert opinion - Top-Institutions - MDSpire

How we diagnose and treat hereditary transthyretin-mediated amyloidosis with polyneuropathy in the Balkan region: an expert opinion

  • By

  • Ivailo Tournev

  • Janez Zidar

  • Borut Peterlin

  • Ervina Bilić

  • Stojan Perić

  • Sonja Pavlović

  • Teodora Chamova

  • June 26, 2026

  • 0 min

Share

Top Institutions in Neurology

Brief introduction explaining scope and methodology.

  • #1

    Bulgaria Center of Excellence
    Bulgaria Center of Excellence

    Sofia, Bulgaria

    Key Differentiators

    • Neurology

  • #2

    University of Zagreb
    University of Zagreb

    Zagreb, Croatia

    Key Differentiators

    • Neurology

  • #3

    University of Belgrade
    University of Belgrade

    Belgrade, Serbia

    Key Differentiators

    • Neurology

  • #4

    University of Ljubljana
    University of Ljubljana

    Ljubljana, Slovenia

    Key Differentiators

    • Neurology

Original Source(s)

How we diagnose and treat hereditary transthyretin-mediated amyloidosis with polyneuropathy in the Balkan region: an expert opinion

  • by Ivailo Tournev, Janez Zidar, Borut Peterlin, Ervina Bilić, Stojan Perić, Sonja Pavlović, Teodora Chamova

  • June 26, 2026

Related Content

HMGB1-TLR4 signaling-mediated neuroinflammation contributes to the pathogenesis of infantile epileptic spasms syndrome in rats

Mast cells: “central regulatory hub” of neuro-endocrine-immune dysregulation in vitiligo

A real-world feasibility study: at home longitudinal use of the Cumulus NeuLogiq® platform for electrophysiological and neurocognitive measures in patients with mild Alzheimer's Disease dementia